GLENMARK LIFE SCIENCES
|
GLENMARK LIFE SCIENCES Last 5 Year Balance Sheet History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹25 Cr | ₹25 Cr | ₹1.96 Cr | ₹1.96 Cr | ₹1.96 Cr |
Equity - Authorised | ₹40 Cr | ₹40 Cr | ₹40 Cr | ₹14 Cr | ₹2.00 Cr |
Equity - Issued | ₹25 Cr | ₹25 Cr | ₹1.96 Cr | ₹1.96 Cr | ₹1.96 Cr |
Equity Paid Up | ₹25 Cr | ₹25 Cr | ₹1.96 Cr | ₹1.96 Cr | ₹1.96 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹2.00 | ₹2.00 | ₹2.00 | ₹10.00 | ₹10.00 |
Share Warrants & Outstandings | ₹6.68 Cr | ₹3.50 Cr | - | - | - |
Total Reserves | ₹2,107 Cr | ₹2,026 Cr | ₹751 Cr | ₹400 Cr | ₹86 Cr |
Securities Premium | ₹1,005 Cr | ₹1,005 Cr | - | - | - |
Capital Reserves | - | - | - | - | - |
Profit & Loss Account Balance | ₹1,102 Cr | ₹1,021 Cr | ₹751 Cr | ₹400 Cr | ₹86 Cr |
General Reserves | - | - | - | - | - |
Other Reserves | - | - | - | - | - |
Reserve excluding Revaluation Reserve | ₹2,107 Cr | ₹2,026 Cr | ₹751 Cr | ₹400 Cr | ₹86 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹2,138 Cr | ₹2,054 Cr | ₹753 Cr | ₹402 Cr | ₹88 Cr |
Minority Interest | - | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | - | - | - | - | - |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | - | - | - | - | - |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | - | - | - | - | - |
Unsecured Loans | - | - | - | - | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹42 Cr | ₹31 Cr | ₹23 Cr | ₹16 Cr | ₹6.86 Cr |
Deferred Tax Assets | ₹1.81 Cr | ₹1.07 Cr | ₹2.03 Cr | ₹0.13 Cr | ₹2.29 Cr |
Deferred Tax Liability | ₹44 Cr | ₹33 Cr | ₹25 Cr | ₹17 Cr | ₹9.14 Cr |
Other Long Term Liabilities | ₹17 Cr | ₹1.20 Cr | - | - | - |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | - | - | - | - | - |
Total Non-Current Liabilities | ₹60 Cr | ₹33 Cr | ₹23 Cr | ₹16 Cr | ₹6.86 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹397 Cr | ₹308 Cr | ₹221 Cr | ₹201 Cr | ₹183 Cr |
Sundry Creditors | ₹397 Cr | ₹308 Cr | ₹221 Cr | ₹201 Cr | ₹183 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹85 Cr | ₹50 Cr | ₹967 Cr | ₹1,084 Cr | ₹1,181 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹1.94 Cr | ₹1.13 Cr | ₹7.29 Cr | ₹5.41 Cr | ₹2.83 Cr |
Interest Accrued But Not Due | - | - | - | - | - |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹83 Cr | ₹49 Cr | ₹959 Cr | ₹1,079 Cr | ₹1,178 Cr |
Short Term Borrowings | - | - | - | ₹0.02 Cr | ₹0.02 Cr |
Secured ST Loans repayable on Demands | - | - | - | - | - |
Working Capital Loans- Sec | - | - | - | - | - |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | - | - | - | ₹0.02 Cr | ₹0.02 Cr |
Short Term Provisions | ₹541 Cr | ₹389 Cr | ₹257 Cr | ₹22 Cr | ₹16 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹525 Cr | ₹375 Cr | ₹237 Cr | ₹8.36 Cr | ₹2.35 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹16 Cr | ₹14 Cr | ₹20 Cr | ₹14 Cr | ₹14 Cr |
Total Current Liabilities | ₹1,023 Cr | ₹747 Cr | ₹1,445 Cr | ₹1,307 Cr | ₹1,380 Cr |
Total Liabilities | ₹3,220 Cr | ₹2,834 Cr | ₹2,221 Cr | ₹1,726 Cr | ₹1,475 Cr |
ASSETS | |||||
Gross Block | ₹936 Cr | ₹706 Cr | ₹652 Cr | ₹595 Cr | ₹476 Cr |
Less: Accumulated Depreciation | ₹156 Cr | ₹116 Cr | ₹79 Cr | ₹49 Cr | ₹19 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹781 Cr | ₹590 Cr | ₹573 Cr | ₹546 Cr | ₹456 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹49 Cr | ₹92 Cr | ₹14 Cr | ₹11 Cr | ₹80 Cr |
Non Current Investments | ₹0.08 Cr | ₹0.08 Cr | ₹0.08 Cr | ₹0.08 Cr | ₹0.08 Cr |
Long Term Investment | ₹0.08 Cr | ₹0.08 Cr | ₹0.08 Cr | ₹0.08 Cr | ₹0.08 Cr |
Quoted | - | - | - | - | - |
Unquoted | ₹0.08 Cr | ₹0.08 Cr | ₹0.08 Cr | ₹0.08 Cr | ₹0.08 Cr |
Long Term Loans & Advances | ₹9.49 Cr | ₹20 Cr | ₹11 Cr | ₹8.44 Cr | ₹7.92 Cr |
Other Non Current Assets | - | - | - | - | - |
Total Non-Current Assets | ₹852 Cr | ₹706 Cr | ₹598 Cr | ₹565 Cr | ₹545 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | - |
Inventories | ₹604 Cr | ₹516 Cr | ₹513 Cr | ₹413 Cr | ₹401 Cr |
Raw Materials | ₹168 Cr | ₹165 Cr | ₹117 Cr | ₹86 Cr | ₹80 Cr |
Work-in Progress | ₹371 Cr | ₹310 Cr | ₹342 Cr | ₹272 Cr | ₹283 Cr |
Finished Goods | ₹49 Cr | ₹25 Cr | ₹35 Cr | ₹35 Cr | ₹19 Cr |
Packing Materials | ₹1.21 Cr | ₹1.25 Cr | ₹1.15 Cr | ₹1.06 Cr | ₹1.03 Cr |
Stores Ā and Spare | ₹15 Cr | ₹15 Cr | ₹18 Cr | ₹19 Cr | ₹18 Cr |
Other Inventory | - | - | - | - | - |
Sundry Debtors | ₹807 Cr | ₹673 Cr | ₹620 Cr | ₹639 Cr | ₹448 Cr |
Debtors more than Six months | ₹4.16 Cr | ₹0.59 Cr | ₹64 Cr | - | - |
Debtors Others | ₹803 Cr | ₹673 Cr | ₹556 Cr | ₹639 Cr | ₹448 Cr |
Cash and Bank | ₹309 Cr | ₹512 Cr | ₹116 Cr | ₹10.00 Cr | ₹2.06 Cr |
Cash in hand | ₹0.09 Cr | ₹0.11 Cr | ₹0.11 Cr | ₹0.11 Cr | ₹0.04 Cr |
Balances at Bank | ₹309 Cr | ₹512 Cr | ₹115 Cr | ₹9.89 Cr | ₹2.02 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹71 Cr | ₹5.96 Cr | ₹70 Cr | ₹34 Cr | ₹62 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹0.14 Cr | ₹0.16 Cr | ₹0.94 Cr | ₹0.34 Cr | - |
Other current_assets | ₹71 Cr | ₹5.79 Cr | ₹69 Cr | ₹33 Cr | ₹62 Cr |
Short Term Loans and Advances | ₹577 Cr | ₹420 Cr | ₹304 Cr | ₹65 Cr | ₹18 Cr |
Advances recoverable in cash or in kind | ₹31 Cr | ₹37 Cr | ₹77 Cr | ₹65 Cr | ₹18 Cr |
Advance income tax and TDS | ₹518 Cr | ₹363 Cr | ₹223 Cr | - | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹28 Cr | ₹19 Cr | ₹2.81 Cr | - | - |
Total Current Assets | ₹2,369 Cr | ₹2,127 Cr | ₹1,623 Cr | ₹1,160 Cr | ₹931 Cr |
Net Current Assets (Including Current Investments) | ₹1,346 Cr | ₹1,381 Cr | ₹178 Cr | ₹-147 Cr | ₹-450 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹3,220 Cr | ₹2,834 Cr | ₹2,221 Cr | ₹1,726 Cr | ₹1,475 Cr |
Contingent Liabilities | ₹2.22 Cr | ₹2.22 Cr | ₹2.22 Cr | ₹2.22 Cr | ₹2.76 Cr |
Total Debt | - | - | - | ₹0.02 Cr | ₹0.02 Cr |
Book Value | 173.97 | 167.38 | 768.11 | 2,049.45 | 449.62 |
Adjusted Book Value | 173.97 | 167.38 | 69.83 | 37.26 | 8.17 |
Compare Balance Sheet of peers of GLENMARK LIFE SCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK LIFE SCIENCES | ₹10,282.7 Cr | 4.3% | -13.3% | 82.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹369,402.0 Cr | 3% | 2.3% | 68.2% | Stock Analytics | |
CIPLA | ₹109,341.0 Cr | 2.5% | 0.4% | 71.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,341.0 Cr | -0.2% | -4.9% | 40.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹99,176.4 Cr | -1.6% | -7% | 23.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,543.1 Cr | 5% | 10.4% | 109.1% | Stock Analytics |
GLENMARK LIFE SCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK LIFE SCIENCES | 4.3% |
-13.3% |
82.6% |
SENSEX | -0.8% |
1.4% |
22.9% |
You may also like the below Video Courses